1673-422X
2005 Issue 3
Advances on fungus infection in cancer patients
jiang yu ; wei yu quan
jiang yu ; wei yu quan
..............page:237-240
Mechanism of peripheral neurotoxicity induced by oxaliplatin
ma yi ; wang zuo ; wang juan
ma yi ; wang zuo ; wang juan
..............page:234-237
Advancements of imatinib in treatment of leukemia and other tumor
luo lin sheng ; zhang ri
luo lin sheng ; zhang ri
..............page:230-233
..............page:226-229
The molecular cytogenetic progress of MALT lymphoma
wang hai ; fan qin he
wang hai ; fan qin he
..............page:224-226
Fas/FasL and malignant lymphoma
lu hong yang ; ma sheng lin ; yu xin min
lu hong yang ; ma sheng lin ; yu xin min
..............page:221-223
Role of serum CA125 in treatment and follow-up of epithelial ovarian carcinoma
zhang xin ; wu ling ying
zhang xin ; wu ling ying
..............page:218-221
Progress of ATP tumor chemoseusitivity assay in gynecologic cancer
nie chun lian ; gao guo lan
nie chun lian ; gao guo lan
..............page:215-218
The relation among EGF, EGFR and hepatocarcinoma
wang wen qi ; xu zuo feng ; liu zuo
wang wen qi ; xu zuo feng ; liu zuo
..............page:212-214
Advances of the relationship between esophagus cancer and cyclooxygenase-2
tai wei ping ; zhang tai chang
tai wei ping ; zhang tai chang
..............page:209-211
Advances in the treatment of non-small cell lung cancer by iressa
fu jian fei ; yuan zuo
fu jian fei ; yuan zuo
..............page:205-209
Risk factors of local recurrence in early breast cancer after breast conserving Surgery
guo gui long ; zhang zuo zuo
guo gui long ; zhang zuo zuo
..............page:202-205
Molecular biologic diagnosis of serous effusions
cao feng ; zhang he
cao feng ; zhang he
..............page:199-201
Progress of the relation between glutamine and chemotherapy of tumor
guo ren hua ; shu yong qian
guo ren hua ; shu yong qian
..............page:196-198
Progress of the relation between tumor chemoresistance and X-linked inhibitor of apoptosis
zuo zhi yuan ; li yi xiong
zuo zhi yuan ; li yi xiong
..............page:193-196
Some new signaling-oriented drugs related to MDR
cao guang sheng ; jiao bo
cao guang sheng ; jiao bo
..............page:190-193
Advance in targets for antitumor drug
lin ru xian ; wang sheng qi
lin ru xian ; wang sheng qi
..............page:186-190
RNA interference in tumor research
wang kai feng ; ye sheng long
wang kai feng ; ye sheng long
..............page:183-186
Urokinase-type plasminogen activator series and tumour metastasis
lv zheng hua ; zuo xin yong
lv zheng hua ; zuo xin yong
..............page:179-182
Progress of the mechanisms of arsenic induced apoptosis in tumor cells
zuo ling ; zheng yu jian
zuo ling ; zheng yu jian
..............page:176-178
Progress in transcriptional control of the human telomerase reverse transcriptase gene
liu yong ping ; kong ying ze ; hu yue zuo
liu yong ping ; kong ying ze ; hu yue zuo
..............page:172-175
Preparation and application of xenogeneic cell vaccine
LUO Feng;LI Yu;ZHOU Lin
LUO Feng;LI Yu;ZHOU Lin
..............page:170-172
The character and clinical application of cancer testis antigen
fan rong ; luo zuo ; xiao shao wen
fan rong ; luo zuo ; xiao shao wen
..............page:166-169
Advances in telomerase as a therapeutic target for malignant tumor
JI Xue-mei;ZHOU Yun-feng
JI Xue-mei;ZHOU Yun-feng
..............page:163-166